A. Christian Whelen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
A. Christian Whelen has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
- Amy M. Woron
Hawaii Department of Health, Pearl City, HI 96782, USA
1 shared publication Bruce C. Kline
Department of Biochemistry and Molecular Biology, Mayo Clinic Rochester, Rochester, Minnesota
1 shared publication- David E. Williams
Departments of Chemistry and Earth, Ocean & Atmospheric Sciences, University of British Columbia, Vancouver, BC V6T 1Z4, Canada
1 shared publication David H. Persing
Division of Infectious Diseases and Internal Medicine, Mayo Clinic Rochester, Rochester, Minnesota
1 shared publication- Endrei Marcantonio
School of Life Sciences, University of Hawaii at Manoa, Honolulu, HI 96822, USA
1 shared publication Franklin R. Cockerill
Division of Clinical Microbiology, Mayo Clinic Rochester, Rochester, Minnesota 55905 USA
1 shared publication
Latest Publications
- Open Access
Proteomic Analysis of Sputum from Patients with Active Tuberculosis
Background: Patients with pulmonary tuberculosis (TB) typically produce sputa, which are used to identify the pathogen. Sputum also contains host proteins that may aid in diagnosis. We hypothesized that sputa from TB patients will have unique proteomes when compared to other lung diseases. Methods: Sputa were collected from 219 patients with suspected TB. Neutrophil-derived protein calprotectin (CP), which was used as a marker for lung damage, was quantified and compared between TB and non-TB groups. Three sputa with high or low CP from each group were selected and analyzed using label-free proteomics. Results: There was no difference in CP amounts between TB and non-TB groups. However, TB samples had other differentially abundant neutrophil-associated proteins. Compared to low CP, samples with high CP had much smaller number of proteins that could differentiate between TB and non-TB groups. Only two proteins, MUC5AC and MMP8, were more abundant in TB samples, regardless of CP levels. Conclusions: Our findings suggest that TB sputa may have unique proteomes that depend on CP levels, which should be further validated due to the small sample size. Therefore, controlled and more advanced TB may need a different set of biomarkers to reliably distinguish TB from other lung diseases.
Open AccessProteomic Analysis of Sputum from Patients with Active Tuberculosis
Background: Patients with pulmonary tuberculosis (TB) typically produce sputa, which are used to identify the pathogen. Sputum also contains host proteins that may aid in diagnosis. We hypothesized that sputa from TB patients will have unique proteomes when compared to other lung diseases. Methods: Sputa were collected from 219 patients with suspected TB. Neutrophil-derived protein calprotectin (CP), which was used as a marker for lung damage, was quantified and compared between TB and non-TB groups. Three sputa with high or low CP from each group were selected and analyzed using label-free proteomics. Results: There was no difference in CP amounts between TB and non-TB groups. However, TB samples had other differentially abundant neutrophil-associated proteins. Compared to low CP, samples with high CP had much smaller number of proteins that could differentiate between TB and non-TB groups. Only two proteins, MUC5AC and MMP8, were more abundant in TB samples, regardless of CP levels. Conclusions: Our findings suggest that TB sputa may have unique proteomes that depend on CP levels, which should be further validated due to the small sample size. Therefore, controlled and more advanced TB may need a different set of biomarkers to reliably distinguish TB from other lung diseases.
- 1 March 1996
- Published by Elsevier in Mayo Clinic Proceedings
- Vol. 71 (3) , 221-229
Prospective Evaluation of the Utility of Molecular Techniques for Diagnosing Nosocomial Transmission of Multidrug-Resistant Tuberculosis
- 1 March 1996
- Published by Elsevier in Mayo Clinic Proceedings
- Vol. 71 (3) , 221-229
Prospective Evaluation of the Utility of Molecular Techniques for Diagnosing Nosocomial Transmission of Multidrug-Resistant Tuberculosis